NIH R15 grants: recently funded projects and award sizes

Academic Research Enhancement Award (AREA/REAP). Research grants for institutions with limited NIH funding, with students in the work.

New awards
165
in the last 12 months
Median award
$553K
first-year award (total costs)
Middle half
$520K to $566K
25th to 75th percentile
Top institute
NIGMS
30 awards

About the NIH R15

The R15 supports meritorious research at institutions that have not been major recipients of NIH funding, while exposing students to research. AREA covers undergraduate-focused institutions; REAP covers health professional and graduate schools.

Eligibility depends on your institution's recent NIH funding, so confirm it with your sponsored programs office before you start.

Project length
Up to 3 years
Budget
A total direct cost limit set in each notice
Research Strategy
Usually 12 pages, including how students will take part
Who applies
Eligible institutions only (based on NIH funding history)

Limits change between notices: the notice you apply to is what counts.

Open NIH R15 opportunities

All NIH funding

Recently funded NIH R15 projects

  • Mechanotransduction from the tumor microenvironment to the nuclear envelope protein emerin enables nuclear softening during cancer metastasis

    James Michael Holaska · Rowan University, NJ · NCI · $564K · Sep 23, 2026

    This project will investigate the mechanism by which mechanical signaling through the inner nuclear envelope protein emerin modulates breast cancer metastasis. Triple-negative breast cancer (TNBC) remains one of the most lethal and therapeutically challenging subtypes of breast cancer due to its high propensity for…

  • Investigating back pain injury mechanisms associated with chronic pain behaviors

    Kelly Roballo · Virginia College of Osteopathic Medicine, VA · NCCIH · $592K · Sep 17, 2026

    In this project, we propose to characterize the pathophysiology of pain from non-penetrating injuries to the thoracolumbar spinal cord. The leading causes of traumatic spinal cord injury (SCI) are motor vehicle accidents (29.9%), falls (29.8%), and sports-related injuries. SCI is characterized by a complex cascade of…

  • Identifying the molecular differences between oncogenic BMI1 and its tumor suppressive paralog, MEL18

    Chongwoo A Kim · Midwestern University (Glendale Az), AZ · NCI · $527K · Sep 17, 2026

    BMI1 and MEL18 are two epigenetic regulatory proteins. They are paralogs, have identical structures and bind the same proteins. Yet, they have opposite effects on cancer cells. BMI1 promotes the oncogenesis of all cancers studied thus far. MEL18, on the other hand, is tumor suppressive whose expression correlates with…

  • Quorum sensing inhibition as an antibacterial strategy against Pseudomonas aeruginosa infections

    Isabelle Taylor · College of William and Mary, VA · NIAID · $549K · Sep 17, 2026

    Project Abstract Pseudomonas aeruginosa is an opportunistic bacterial pathogen that is responsible for causing highly resistant infections. The ability to establish infections and evade antibiotic treatment stems from the heightened ability of P. aeruginosa to carry out collective group behaviors, such as biofilm…

  • Metal-dependent Protein Phosphatases as Key Regulators of Neurodegeneration in Parkinson’s disease

    An-Phu Tran · University of Wisconsin Milwaukee, WI · NINDS · $576K · Sep 17, 2026

    Parkinson’s disease (PD) is a progressive and currently incurable brain disorder that affects movement and other functions. The disease develops as dopamine-producing nerve cells in a specific region of the brain gradually die, leading to symptoms such as tremors, stiffness, and slowed movements. Most cases of PD…

  • Synaptic architecture and bidirectional signaling of retinal horizontal and dopaminergic circuits

    Jordan Michael Renna · University of Akron, OH · NEI · $425K · Sep 16, 2026

    Vision begins in the outer retina, where photoreceptors transmit graded signals through specialized ribbon synapses to bipolar and horizontal cells. These interactions establish the first computations of vision including contrast, color opponency, and adaptation. Yet despite a century of study since Cajal’s original…

  • TinyML-Driven Closed-Loop Deep Brain Stimulation for Parkinson's Disease

    Chunxiu Yu · Michigan Technological University, MI · NINDS · $550K · Sep 14, 2026

    Deep brain stimulation (DBS) is a clinically established therapy for advanced Parkinson’s disease (PD), providing symptom relief through continuous high-frequency stimulation of targeted brain regions. However, conventional open-loop DBS delivers non-adaptive stimulation that cannot respond to dynamic neural or…

  • Phospho-Regulation of Centrosome Assembly and Function

    Mi Hye Song · Oakland University, MI · NIGMS · $574K · Sep 10, 2026

    Program Director/Principal Investigator (Last, First, Middle): Song, Mi Hye Project Summary Precise regulation of centrosome duplication is crucial for proper cell division and maintaining genomic stability. Errors in this process lead to centrosome amplification and chromosomal instability, contributing to cancer,…

  • Blacklegged tick exposure and management among understudied rural human populations

    Allison Gardner · University of Maine Orono, ME · NIAID · $535K · Sep 9, 2026

    This AREA research will conduct a synthetic investigation of environmental and social conditions contributing to tick exposure and willingness to adopt tick management strategies in a rural, high-Lyme disease incidence state. Residents of rural areas are disproportionately affected by tick-borne disease in the United…

  • Molecular Devices for Calorimetric Measurements

    Irina V Nesterova · Northern Illinois University, IL · NIGMS · $476K · Sep 9, 2026

    Understanding how biomolecules interact is essential for progress in biomedical research. All chemical and biochemical reactions involve heat transformations; quantitative assessment of heat is a fundamental characteristic that reveals the reaction mechanism, nature and strength of ligand/receptor binding,…

  • Repurposing antifolate compounds as W. bancrofti DHFR inhibitors

    Nina M Goodey · Montclair State University, NJ · NIAID · $580K · Sep 8, 2026

    Lymphatic filariasis is a neglected tropical disease affecting quality of life for over 100 million people, with few treatment options that effectively clear adult-stage Wuchereria bancrofti (Wb) parasites. Current treatment options rely on non-specific anthelmintics such as diethylcarbamazine, albendazole, and…

  • Impact of sulfated glycans on HSV-1 mediated entry and inflammation in iris stroma derived from human eye donors

    Vaibhav Tiwari · Midwestern University, IL · NIAID · $559K · Sep 8, 2026

    (ABSTRACT) Herpes simplex virus type 1 (HSV-1) is a significant pathogen of acute anterior uveitis, a recurrent, vision- threatening condition that can result in cataracts, glaucoma, and irreversible vision loss. The iris, a specialized tissue of the anterior segment, is particularly vulnerable to HSV-1 infection and…

  • Identifying the Spinal Molecular Mechanisms of Chronic Pain Induced by Systemic Lupus Erythematosus

    Han-Rong Weng · Northern California Health Services and Research Foundation, CA · NIAMS · $413K · Sep 7, 2026

    Chronic pain is a prevalent and debilitating complication for patients with systemic lupus erythematosus (SLE) due to the limited efficacy and safety of currently available analgesics. Understanding the cellular and molecular mechanisms underlying SLE-induced chronic pain is a foundation for creating novel strategies…

  • Improving the Assessment of Great Toe Function and its Association with Gait and Balance in Older Adults

    Jeff Andrew Nessler · California State University San Marcos, CA · NIA · $541K · Sep 4, 2026

    The primary goal of this project is to determine the relationship between novel measures of great toe function and established measures of gait variability and balance in both younger and older adults. A secondary goal is to develop additional methods for measuring great toe function that are more functionally and…

  • Advancing tremor decomposition for personalized treatment in Essential Tremor: Moving from feasibility toward clinical application

    Steven Knight Charles · Brigham Young University, UT · NIA · $552K · Sep 4, 2026

    Tremor is the most common movement disorder, estimated to affect at least 6-9% of persons aged 60 or older in the US. Most tremor disorders manifest as oscillations of the upper limbs while at rest, maintaining a posture, and/or moving, making activities of daily living (eating, clothing, grooming, etc.) difficult or…

Institutions with the most new NIH R15 awards

  1. 1Brigham Young University, UT5
  2. 2Rowan University, NJ5
  3. 3Baylor University, TX4
  4. 4Texas Tech University, TX4
  5. 5University of Toledo, OH4
  6. 6Worcester Polytechnic Institute, MA4
  7. 7College of William and Mary, VA3
  8. 8East Carolina University, NC3
  9. 9East Tennessee State University, TN3
  10. 10Illinois State University, IL3

How to write it

All guides
Writing an NIH R15 application?

Grantee reads the notice, sets up every required section with its page limit and drafts each one with you, then checks the draft against the requirements before you submit.

Start free

Get new funding every Monday

New federal opportunities and upcoming deadlines for NIH R15 and more, in one short email. Free, unsubscribe anytime.

New NIH R15 awards with notice dates from Oct 27, 2025 to Oct 27, 2026, from NIH RePORTER. Amounts are the first-year award, direct plus indirect costs. Updated Oct 27, 2026.